Q2 2022 Holdings
Filed 2022-08-05 | 668 holdings | $124.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ARK ETF TR(ARKK) | INNOVATION ETF | 00214Q104 | $101.7M | 2,550,000 | 81.5% |
| Apyx Medical Corporation(APYX) | COM | 03837C106 | $16.5M | 2,818,341 | 13.2% |
| Aersale Corporation(ASLE) | COM | 00810F106 | $2.6M | 178,803 | 2.1% |
| Canna Global Acquisition COR(CNGL) | CLASS A COM | 13767K101 | $1.0M | 100,000 | 0.8% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $602.0K | 27,132 | 0.5% |
| Cornerstone Strategic Value(CLM) | COM | 21924B302 | $462.0K | 53,828 | 0.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $313.0K | 1,536 | 0.3% |
| Beam Global(BEEM) | COM | 07373B109 | $233.0K | 15,000 | 0.2% |
| Camping World Hldgs Inc(CWH) | CL A | 13462K109 | $216.0K | 10,000 | 0.2% |
| Advisorshares TR(MSOS) | PURE US CANNABIS | 00768Y453 | $104.0K | 10,000 | 0.1% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $80.0K | 124,590 | 0.1% |
| Sylvamo Corp(SLVM) | COMMON STOCK | 871332102 | $70.3K | 2,150,000 | 0.1% |
| Biote Corp(BTMD) | CLASS A COM | 090683103 | $49.0K | 12,970 | 0.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $45.5K | 836,654 | 0.0% |
| Dish Network Corporation | NOTE 3.375% 8/1 | 25470MAB5 | $37.2K | $55,367,000 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $35.7K | 2,443,780 | 0.0% |
| SEA LTD | NOTE 0.250% 9/1 | 81141RAG5 | $33.6K | $45,774,667 | 0.0% |
| Sumitomo Mitsui Finl Group I(SMFG) | SPONSORED ADR | 86562M209 | $33.5K | 5,676,605 | 0.0% |
| Fortress Trans Infrst Invs L | CL A COM SHS | 34960P101 | $33.1K | 1,710,550 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $32.9K | 2,264,150 | 0.0% |
| Jetblue Airways Corp | NOTE 0.500% 4/0 | 477143AP6 | $31.8K | $42,885,000 | 0.0% |
| Revance Therapeutics Inc | NOTE 1.750% 2/1 | 761330AB5 | $30.8K | $36,800,000 | 0.0% |
| Cutera Inc(CUTREUR) | COM | 232109108 | $22.4K | 596,305 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $20.3K | 1,066,854 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $19.9K | 1,509,620 | 0.0% |
| Pershing Square Tontine Hldg | COM CL A | 71531R109 | $19.0K | 952,000 | 0.0% |
| Sciplay Corporation(2XY) | CL A | 809087109 | $18.8K | 1,346,246 | 0.0% |
| Innoviz Technologies LTD(INVZ) | SHS | M5R635108 | $18.7K | 4,771,390 | 0.0% |
| Draftkings Inc New | NOTE 3/1 | 26142RAB0 | $17.0K | $28,000,000 | 0.0% |
| Cantaloupe Inc(CTLP) | COM | 138103106 | $16.6K | 2,963,188 | 0.0% |
| Project Energy Reimagined AC | CLASS A ORD | G72556106 | $14.6K | 1,500,000 | 0.0% |
| Hennessy Capital Invst Corp | UNIT 99/99/9999 | 42600H207 | $14.6K | 1,500,000 | 0.0% |
| Energy Transfer L P(ET) | COM UT LTD PTN | 29273V100 | $14.3K | 1,435,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $13.8K | 1,000,000 | 0.0% |
| Redball Acquisition Corp | COM CL A | G7417R105 | $12.5K | 1,251,692 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $11.7K | 2,385,885 | 0.0% |
| 26 Capital Acquisition Corp | COM CL A | 90138P100 | $9.8K | 1,000,000 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $9.1K | 3,732,778 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $8.6K | 2,843,149 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $8.4K | 1,065,724 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $8.0K | 1,500,000 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $7.8K | 534,524 | 0.0% |
| Exagen Inc(XGN) | COM | 30068X103 | $7.8K | 1,355,414 | 0.0% |
| Brookfield Asset Mgmt Reins(BAM) | CL A EXCH LT VTG | G16169107 | $7.1K | 158,479 | 0.0% |
| Alpha Healthcare Acqu Corp I | UNIT 04/01/2026 | 02073F203 | $6.8K | 700,000 | 0.0% |
| B Riley Principal 150 Merger | COM CL A | 05601V103 | $6.5K | 647,549 | 0.0% |
| The ODP Corp(ODP1) | COM | 88337F105 | $6.3K | 209,681 | 0.0% |
| Switch Inc | CL A | 87105L104 | $6.2K | 186,100 | 0.0% |
| Better World Acquisition COR | COM | 08772B104 | $5.7K | 550,000 | 0.0% |
| Bluescape Opportunities Acqu | SHS | G1195N105 | $5.6K | 569,891 | 0.0% |